In The News Posted October 7, 2019 Share Posted October 7, 2019 CENTENNIAL, Colo., Oct. 7, 2019 /PRNewswire/ -- AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced research results showing ProChondrix® CR maintains consistent, high cell viability for two years when... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.